Secoxyloganin inhibits growth of breast cancer MDA-MB-231 cells via induction of apoptosis and cell cycle arrest

This study was set to study the anti-proliferative effects of secoxyloganin in MDA-MB-231 breast cancer cells. The MTT cell viability assay results demonstrated that secoxyloganin significantly (p < 0.05) inhibited the growth of the MDA-MB-231 cells with an IC50 of 6.5 μM which was significantly...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Ma, Cong Peng
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:All Life
Subjects:
Online Access:http://dx.doi.org/10.1080/26895293.2024.2408433
Tags: Add Tag
No Tags, Be the first to tag this record!